Pfizer Inc (MIL:1PFE)
€ 25 -0.395 (-1.56%) Market Cap: 140.28 Bil Enterprise Value: 192.77 Bil PE Ratio: 36.11 PB Ratio: 1.64 GF Score: 63/100

Pfizer Inc at JPMorgan U.S. All Stars Conference Transcript

Sep 18, 2023 / 10:00AM GMT
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst

We're ready to go. So good morning, everybody. I'm Chris Schott, the pharma analyst here at JPMorgan, and it's my pleasure to be hosting a fireside chat today with Pfizer. From the company, we have Dave Denton, the company's CFO, and before we jump into, which will be, I'm sure, a very interesting discussion. We have Ronen, from the IR team, read disclosure here, and then we'll dive into the conversation from there.

Ronen Tamir
Pfizer Inc. - VP of IR

Thank you, Chris. I just wanted to inform you that we are going to be making some forward-looking statements. And then we're going to be making those looking forward statements that are true for today. And if you have any additional questions, on the forward-looking statements, please see the relevant sectors in our SEC filing on the Forms 10-Q and 10-K. Thank you.

Questions & Answers

Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot